On September 17, 2025, XOMA Royalty Corp completed the acquisition of HilleVax, Inc., following a successful tender offer where 39,214,689 shares were accepted, equating to approximately 77.48% of HilleVax’s outstanding shares, at a cash price of $1.95 per share plus potential future payments through a contingent value right. This merger marks a significant event for XOMA.